Allspring Global Investments’s Stoke Therapeutics STOK Stock Holding History

Allspring Global Investments’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$683K	Sell	20,985 -3,477	-14%	-$114K	﹤0.01%	1297
2025 Q4	$756K	Sell	24,462 -10,596	-30%	-$319K	﹤0.01%	1242
2025 Q3	$824K	Sell	35,058 -346	-1%	-$5.93K	﹤0.01%	1207
2025 Q2	$402K	Buy	+35,404	New	+$336K	﹤0.01%	1402
2023 Q4	–	Sell	-14,790	Closed	-$58.3K	–	2706
2023 Q3	$58.3K	Sell	14,790 -144	-1%	-$947	﹤0.01%	2210
2023 Q2	$159K	Sell	14,934 -214	-1%	-$2.28K	﹤0.01%	1885
2023 Q1	$126K	Sell	15,148 -152	-1%	-$1.37K	﹤0.01%	1960
2022 Q4	$141K	Buy	+15,300	New	+$159K	﹤0.01%	1943

Other funds holding STOK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Allspring Global Investments's STOK Position: Q1 2026 in Review

Allspring Global Investments reduced its Stoke Therapeutics (STOK) stake by 14% in Q1 2026, selling an estimated $114K and leaving 20,985 shares worth $683K. The position accounts for ﹤0.01% of the portfolio, ranked #1297.

Allspring Global Investments first reported a position in STOK in Q4 2022 and has held it in 8 quarters since. The position peaked at $824K in Q3 2025. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

Allspring Global Investments held 20,985 shares of Stoke Therapeutics worth $683K as of Q1 2026.
Allspring Global Investments sold 3,477 Stoke Therapeutics shares in Q1 2026, an estimated $114K.
Stoke Therapeutics made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1297 holding.
Allspring Global Investments first reported a position in Stoke Therapeutics in Q4 2022 and has held it in 8 quarters since.
Allspring Global Investments's Stoke Therapeutics position peaked at $824K in Q3 2025.
196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.